The stress response: Implications for the clinical development of Hsp90 inhibitors

Current Cancer Drug Targets

Volumn 3, Issue 5, 2003, Pages 349-358

  Whitesell, Luke ^a,b   Bagatell, Rochelle ^a   Falsey, Ryan ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; ACETYLSALICYLIC ACID; CHAPERONE; DNA; GELDANAMYCIN; HEAT SHOCK FACTOR 1; HEAT SHOCK FACTOR 2; HEAT SHOCK FACTOR 4; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; IBUPROFEN; INDOMETACIN; PROTEIN INHIBITOR; QUERCETIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG MONITORING; DRUG RESPONSE; ENZYME REGULATION; GENE EXPRESSION; HEART DISEASE; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INDUCTION; REVIEW; STROKE;

ANIMALS; ANTINEOPLASTIC AGENTS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; STRESS;

EID: 0141819958     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009033481787     Document Type: Review

References (100)

1. Smith, D. F.; Whitesell, L.; Katsanis, E. Molecular Chaperones: Biology and Prospects for Pharmacological Intervention. Pharmacol. Rev. 1998, 50, 493-513.
2. Gerner, E. W.; Schneider, M. J. Induced Thermal Resistance in Hela Cells. Nature 1975, 256, 500-502.
3. Wang, S. M.; Khandekar, J. D.; Kaul, K. L.; Winchester, D. J.; Morimoto, R. I. A Method for the Quantitative an alysis of Human Heat Shock Gene Expression Using a Multiplex RT-PCR Assay. Cell Stress Chap. 1999, 4, 153-161.
4. Frydman, J. Folding of Newly Translated Proteins in Vivo: the Role of Molecular Chaperones. Annu. Rev. Biochem. 2001, 70, 603-647.
5. Csermely, P.; Schnaider, T.; Soti, C.; Prohaskka, Z.; Nardai, G. The 90-Kda Molecular Chaperone Family: Structure, Function, and Clinical Applications. A Comprehensive Review. Pharmacol. Ther. 1998, 79, 129-168.
6. Morimoto, R. I.; Santoro, M. G. Stress-Inducible Responses and Heat Shock Proteins: New Pharmacologic Targets for Cytoprotection. Nature Biotech. 1998, 16, 833-838.
7. Maloney, A.; Workman, P. Hsp90 as a New Therapeutic Target for Cancer Therapy: the Story Unfolds. Expert Opin. Biol. Ther. 2002, 2, 3-24.
8. Piper, P. W. The Hsp90 Chaperone as a Promising Drug Target. Curr. Opin. Invest. Drugs 2001, 2, 1606-1610.
9. Nakai, A. New Aspects in the Vertebrate Heat Shock Factor System: Hsf3 and Hsf4. Cell Stress Chap. 1999, 4, 86-93.
10. Nakai, A.; Morimoto, R. I. Characterization of a Novel Chicken Heat Shock Transcription Factor, HSF3, Suggests a New Regulatory Pathway. Mol. Cell Biol. 1993, 13, 1983-1997.
11. Sorger, P. K. Heat Shock Factor and the Heat Shock Response. Cell 1991, 65, 363-366.
12. Goodson, M. L.; Sarge, K. D. Heat-Inducible DNA Binding of Purified Heat Shock Transcription Factor 1. J. Biol. Chem. 1995, 270, 2447-2450.
13. Morano, K. A.; Thiele, D. J. Heat Shock Factor Function and Regulation in Response to Cellular Stress, Growth and Differentiation Signals. Gene. Exp. 1999, 7, 271-282.
14. Rallu, M.; Loones, M. T.; Lallemand, Y.; Morimoto, R. I.; Morange, M.; Mezger, V. Function and Regulation of Heat Shock Factor 2 During Mouse Embryogenesis. Proc. Natl. Acad. Sci. USA 1997, 94, 2392-2397.
15. Sistonen, L.; Sarge, K. D.; Phillips, B.; Morimoto, R. I. Activation of Heat Shock Factor 2 During Hemin-Induced Differentiation of Human Erythroleukemnia Cells. Mol. Cell Biol. 1992, 12, 4104-4111.
16. Leppa, S.; Pirkkala, L.; Saarento, H.; Sarge, K. D.; Sistonen, L. Overexpression of HSF2-Beta Inhibits Hemin-Induced Heat Shock Gene Expression and Erythroid Differentiation in K562 Cells. J. Biol. Chem. 1997, 272, 15293-15298.
17. Dai, R.; Frejtag, W.; He, B.; Zhang, Y.; Mivechi, N. F. JNK Targeting and Phosphorylation of Heat Shock Factor-1 Suppress Its Transcriptional Activity. J. Biol. Chem. 2000, 275, 18210-18218.
18. Morimoto, R. I. Regulation of the Heat Shock Transcriptional Response: Cross Talk Between a Family of Heat Shock Factors, Molecular Chaperones, and Negative Regulators. Genes. Devel. 1998, 12, 3788-3796.
19. Pirkkala, L.; Nykanen, P.; Sistonen, L. Roles of the Heat Shock Transcription Factors in Regulation of the Heat Shock Response and Beyond. FASEB J. 2001, 15, 1118-1131.
20. Mcmillan, D. R.; Xiao, X.; Shao, L.; Graves, K.; Benjamin, I. J. Targeted Disruption of Heat Shock Transcription Factor 1 Abolishes Thermotolerance and Protection against Heat-Inducible Apoptosis. J. Biol. Chem. 1998, 273, 7523-7528.
21. Xiao, X.; Zuo, X.; Davis, A. A.; Mcmillan, D. R.; Curry, B. B.; Richardson, J. A.; Benjamin, I. J. HSF1 Is Required for Extra-Embryonic Development, Postnatal Growth and Protection During Inflammatory Responses in Mice. EMBO J. 1999, 18, 5943-5952.
22. Kline, M. P.Morimoto, R. I. Repression of the Heat Shock Factor 1 Transcriptional Activation Domain Is Modulated by Constitutive Phosphorylation. Mol. Cell Biol. 1997, 17, 2107-2115.
23. Chu, B.; Zhong, R.; Soncin, F.; Stevenson, M. A.; Calderwood, S. K. Transcriptional Activity of Heat Shock Factor 1 At 37 Degrees C Is Repressed Through Phosphorylation on Two Distinct Serine Residues by Glycogen Synthase Kinase 3 and Protein Kinases Calpha and Czeta. J. Biol. Chem. 1998, 273, 18640-18646.
24. Zou, J.; Guo, Y.; Guettouche, T.; Smith, D. F.; Voellmy, R. Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) That Forms a Stress-Sensitive Complex with HSF1. Cell 1998, 94, 471-480.
25. Ali, A.; Bharadwaj, S.; O'Carroll, R.; Ovsenek, N. HSP90 Interacts with and Regulates the Activity of Heat Shock Factor 1 in Xenopus Oocytes. Mol. Cell Biol. 1998, 18, 4949-4960.
26. Bharadwaj, S.; Ali, A.; Ovsenek, N. Multiple Components of the HSP90 Chaperone Complex Function in Regulation of Heat Shock Factor 1 in Vivo. Mol. Cell Biol. 1999, 19, 8033-8041.
27. Nair, S. C.; Toran, E. J.; Rimerman, R. A.; Hjermstad, S.; Smithgall, T. E.; Smith, D. F. A Pathway of Multi-Chaperone Interactions Common to Diverse Regulatory Proteins: Estrogen Receptor, Fes Tyrosine Kinase, Heat Shock Transcription Factor HSF1, and the Aryl Hydrocarbon Receptor. Cell Stress Chap. 1996, 1, 237-250.
28. Nadeau, K.; Das, A.; Walsh, C. T. Hsp90 Chaperonins Possess Atpase Activity and Bind Heat Shock Transcription Factors and Peptidyl Prolyl Isomerases. J. Biol. Chem. 1993, 268, 1479-1487.
29. Cotto, J. J.; Kline, M.; Morimoto, R. I. Activation of Heat Shock Factor 1 DNA Biniding Precedes Stress-Induced Serine Phosphorylation. J. Biol. Chem. 1996, 271, 3355-3358.
30. Xia, W.; Voellmy, R. Hyperphosphorylation of Heat Shock Transcription Factor 1 Is Correlated with Transcriptional Competence and Slow Dissociation of Active Factor Trimers. J. Biol. Chem. 1997, 272, 4094-4102.
31. Hong, Y.; Rogers, R.; Matunis, M. J.; Mayhew, C. N.; Goodson, M.; Park-Sarge, O. K.; Sarge, K. D. Regulation of Heat Shock Transcription Factor 1 by Stress-Induced SUMO-I Modification. J. Biol. Chem. 2001, 276, 40263-40267.
32. Cotto, J. J.; Morimoto, R. I. Stress-Induced Activation of the Heat-Shock Response: Cell and Molecular Biology of Heat-Shock Factors. Biochem. Soc. Symp. 1999, 64, 105-118.
33. Shi, Y.; Mosser, D. D.; Morimoto, R. I. Molecular Chaperones as HSF1-Specific Transcriptional Repressors. Genes. Devel. 1998, 12, 654-666.
34. Guo, Y.; Guettouche, T.; Fenna, M.; Boellmann, F.; Pratt, W. B.; to ft, D. O.; Smith, D. F.; Voellmy, R. Evidence for a Mechanism of Repression of Heat Shock Factor 1 Transcriptional Activity by a Multichaperone Complex. J. Biol. Chem. 2001, 276, 45791-45799.
35. Hegde, R.; Zuo, J.; Voellmy, R.; Welch, W. Short Circuiting Stress Protein Expression Via a Tyrosine Kinase Inhibitor, Herbimycin A. J. Cell Physiol. 1995, 165, 186.
36. Murakami, Y.; Uehara, Y.; Yamamoto, C.; Fukazawa, H.; Mizuno, S. Induction of Hsp72/73 by Herbimycin A, an Inhibitor of Transformation by Tyrosine Kinase Oncogenes. Exp. Cell Res. 1991, 195, 338-344.
37. Bagatell, R.; Paine-Murrieta, G.; Taylor, C.; Pulcini, E.; Akinaga, S.; Benjamin, I.; Whitesell, L. Induction of a Heat Shock Factor 1-Dependent Stress Response Alters the Cytotoxic Activity of Hsp90 Binding Agents. Clin. Cancer Res. 2000, 6, 3312-3318.
38. Mercier, P. A.; Foksa, J.; Ovsenek, N.; Westwood, J. T. Xenopus Heat Shock Factor 1 Is a Nuclear Protein Before Heat Stress. J. Biol. Chem. 1997, 272, 14147-14151.
39. Jolly, C.; Usson, Y.; Morimoto, R. I. Rapid and Reversible Relocalization of Heat Shock Factor 1 Within Seconds to Nuclear Stress Granules. Proc. Natl. Acad. Sci. USA 1999, 96, 6769-6774.
40. Whitesell, L.; Sutphin, P.; An, W. G.; Schulte, T.; Blagosklonny, M. V.; Neckers, L. Geldanamycin-Stmulated Destabilization of Mutated p53 is Mediated by the Proteasome in vivo. Oncogene 1997, 14, 2809-2816.
41. Schneider, C.; Sepp-Lorenzino, L.; Nimmesgern, E.; Ouerfelli, O.; Danishefsky, S.; Rosen, N.; Hartl, F. U, Pharmacologic Shifting of a Balance Between Protein Refolding and Degradation Mediated by Hsp90. Proc. Natl. Acad. Sci. USA 1996, 93, 14536-14541.
42. Ashok, B. T.; Kim, E.; Mittelman, A.; Tiwari, R. K. Proteasome Inhibitors Differentially Affect Heat Shock Protein Response in Cancer Cells. Int. J. MoL Med. 2001, 8, 385-390.
43. Fleming, J. A.; Lightcap, E. S.; Sadis, S.; Thoroddsen, V.; Bulawa, C. E.; Blackman, R. K. Complementary Whole-Genome Technologies Reveal the Cellular Response to Proteasome Inhibition by PS-341. Proc. Natl. Acad. Sci. USA 2002, 99, 1461-1466.
44. Mimnaugh, E. G.; Neckers, L. Biologic Rationale for the Combination of an Hsp90 an tagonist with a Proteasome Inhibitor. Clin. Cancer Res. 2001, 7 (Supplement), 3779s.
45. Holmberg, C. I.; Hietakangas, V.; Mikhailov, A.; Rantanen, J. O.; Kallio, M.; Meinander, A.; Hellman, J.; Morrice, N.; Mackintosh, C.; Morimoto, R. I.; Eriksson, J. E.; Sistonen, L. Phosphorylation of Serine 230 Promotes Inducible Transcriptional Activity of Heat Shock Factor 1. EMBO J. 2001, 20, 3800-3810.
46. Dikalov, S.; Landmesser, U.; Harrison, D. G. Geldanamycin Leads to Superoxide Formation by Enzymatic and Non-Enzymatic Redox Cycling. Implications for Studies of Hsp90 and Endothelial Cell Nitric-Oxide Synthase. J. Biol. Chem. 2002, 277, 25480-25485.
47. Schulte, T. W.; Akinaga, S.; Soga, S.; Sullivan, W.; Stensgard, B.; Toft, D.; Neckers, L. M. Antibiotic Radicicol Binds to the N-Terminal Domain of Hsp90 and Shares Important Biologic Activities with Geldanamycin. Cell Stress Chap. 1998, 3, 100-108.
48. Lawson, B.; Brewer, J. W.; Hendershot, L. M. Geldanamycin, an Hsp90/GRP94-Binding Drug, Induces Increased Transcription of Endoplasmic Reticulum (ER) Chaperones Via the ER Stress Pathway. J. Cell Physiol. 1998, 174, 170-178.
49. Ma, Y.; Hendershot, L. M. The Unfolding Tale of the Unfolded Protein Response. Cell 2001, 107, 827-830.
50. Kimura, E.; Erns, R. E.; Alcaraz, J. E.; Arboleda, J.; Slamon, D. J.; Howell, S. B. Correlation of the Survival of Ovarian Cancer Patients with Mrna Expression of the 60kda Heat Shock Protein Hsp60. J. Clin. Oncol. 1993, 11, 891-898.
51. Ciocca, D. R.; Clark, G. M.; Tandon, A. K.; Fuqua, S. A. W.; Welch, W. J.; Mcguire, W. L. Heat Shock Protein Hsp70 in Patients with Axillary Lymph Node- Negative Breast Cancer: Prognostic Implications. J. Natl. Cancer Inst. 1993, 85, 570-574.
52. Conroy, S. E.; Sasieni, P. D.; Fentiman, I.; Latchman, D. S. Autoantibodies to the 90kda Heat Shock Protein and Poor Survival in Breast Cancer Patients. Eur. J. Cancer 1998, 34, 942-943.
53. Ralhan, R.; Kaur, J. Differential Expression of Mr 70,000 Heat Shock Protein in Normal, Premalignant, and Malignant Human Uterine Cervix. Clin. Cancer Res. 1995, 1, 1217-1222.
54. Kaur, J.; Ralhan, R. Differential Expression of 70-Kda Heat Shock-Protein in Human Oral Tumorigenesis. Int. J Cancer 1995, 63, 774-779.
55. Santarosa, M.; Favaro, D.; Quaia, M.; Galligioni, E. Expression of Heat Shock Protein 72 in Renal Cell Carcinoma: Possible Role and Prognostic Implications in Cancer Patients. Euro. J. Cancer. 1997, 33, 873-877.
56. Chant, I. D.; Rose, P. E.; Morris, A. G. an alysis of Heat Shock Protein Expression in Myeloid Leukaemia Cells by Flow Cytometry. Br. J. Haematol. 1995, 90, 163-168.
57. Yufu, Y.; Nishimura, J.; Nawata, H. High Constitutive Expression of Heat Shock Protein 90a in Human Acute Leukemia Cells. Leuk. Res. 1992, 16, 597-605.
58. Jameel, A.; Skilton, R. A.; Campbell, T. A.; Chander, S. K.; Coombes, R. C.; Luqmani, Y. A. Clinical and Biological Significance of Hsp90a in Human Breast Cancer. Int. J. Cancer 1992, 50, 409-415.
59. Yano, M.; Naito, Z.; Tanaka, S.; Asano, G. Expression and Roles of Heat Shock Proteins in Human Breast Cancer. Jpn. J. Cancer Res. 1996, 87, 908-915.
60. Nanbu, K.; Konishi, I.; Mandai, M.; Kuroda, H.; Hamid, A. A.; Komatsu, T.; Mori, T. Prognostic Significance of Heat Shock Proteins HSP70 and HSP90 in Endometrial Carcinomas. Cancer Detection & Prevention, 1998, 22, 549-555.
61. Trieb, K.; Gerth, R.; Holzer, G.; Grohs, J. G.; Berger, P.; Kotz, R. an tibodies to Heat Shock Protein 90 in Osteosarcoma Patients Correlate with Response to Neoadjuvant Chemotherapy. Br. J. Cancer 2000, 82, 85-87.
62. Jaattela, M. Escaping Cell Death: Survival Proteins in Cancer. Exp. Cell Res. 1999, 248, 30-43.
63. Hannun, Y. Apoptosis and the Dilemma of Cancer Chemotherapy. Blood 1997, 89, 1845-1853.
64. Sliutz, G.; Karlseder, J.; Tempfer, C.; Orel, L.; Holzer, G.; Simon, M. M. Drug Resistance against Gemcitabine and Topotecan Mediated by Constitutive Hsp70 Overexpression in Vitro: Implication of Quercetin as Sensitizer in Chemotherapy. Br. J. Cancer 1996, 74, 172-177.
65. Beere, H. M.; Wolf, B. B.; Cain, K.; Mosser, D. D.; Mahboubi, A.; Kuwana, T.; Tailor, P.; Morimoto, R. I.; Cohen, G. M.; Green, D. R. Heat-Shock Protein 70 Inhibits Apoptosis by Preventing Recruitment of Procaspase-9 to the Apaf-1 Apoptosome. Nature Cell Biol. 2000, 2, 469-475.
66. Saleh, A.; Srinivasula, S. M.; Balkir, L.; Robbins, P. D.; Alnemri, E. S. Negative Regulation of the Apaf-1 Apoptosome by Hsp70. Nature Cell Biol. 2000, 2, 476-483.
67. Mosser, D. D.; Caron, A. W.; Bourget, L.; Meriin, A. B.; Sherman, M. Y.; Morimoto, R. I.; Massie, B. The Chaperone Function of Hsp70 Is Required for Protection against Stress-Induced Apoptosis. Mol. Cell Biol. 2000, 20, 7146-7159.
68. Nylandsted, J.; Rohde, M.; Brand, K.; Bastholm, L.; Elling, F.; Jaattela, M. Selective Depletion of Heat Shock Protein 70 (Hsp70) Activates a Tumor-Specific Death Program That Is Independent of Caspases and Bypasses Bcl-2. Proc. Natl. Acad. Sci. USA 2000, 97, 7871-7876.
69. Nathan, D. E.; Vos, M. H.; Lindquist, S. in Vivo Functions of the Saccharomyces Cerevisiae Hsp90 Chaperone. Proc. Natl. Acad Sci. USA 1997, 94, 12949-12956.
70. Pratt, W. B. The Hsp90-Based Chaperone System: Involvement in Signal Transduction From a Variety of Hormone and Growth Factor Receptors. Proc. Soc. Exp. Biol. Med. 1998, 217, 420-431.
71. Morimoto, R. I. Dynamic Remodeling of Transcription Complexes by Molecular Chaperones. Cell 2002, 110, 281-284.
72. Smith, D. F. Dynamics of Heat Shock Protein 90-Progesterone Receptor Binding and the Disactivation Loop Model for Steroid Receptor Complexes. Mol. Endo. 1993, 7, 1418-1429.
73. Whitesell, L.; Mimnaugh, E. G.; De Costa, B.; Myers, C. E.; Neckers, L. M. Inhibition of Heat Shock Protein HSP90-Pp60v-Src Heteroprotein Complex Formation by Benzoquinone an samycins: Essential Role for Stress Proteins in Oncogenic Transformation. Proc. Natl. Acad. Sci. USA 1994, 91, 8324-8328.
74. Whitesell, L.; Sutphin, P. D.; Pulcini, E. J.; Martinez, J. D.; Cook, P. H. The Physical Association of Multiple Molecular Chaperone Proteins with Mutant p53 Is Altered by Geldanamycin, an Hsp90-Binding Agent. Mol. Cell Biol. 1998, 18, 1517-1524.
75. Blagosklonny, M. V.; to retsky, J.; Bohen, S.; Neckers, L. Mutant Conformation of p53 Translated in Vitro or in Vivo Requires Functional HSP90. Proc. Natl. Acad. Sci. USA 1996, 93, 8379-8383.
76. Sepehrnia, B.; Paz, I. B.; Dasgupta, G.; Momand, J. Heat Shock Protein 84 Forms a Complex with Mutant p53 Protein Predominantly within a Cytoplasmic Compartment of the Cell. J. Biol. Chem. 1996, 271, 15084-15090.
77. Rutherford, S. L.; Lindquist, S. Hsp90 as a Capacitor for Morphological Evolution. Nature 1998, 396, 336-342.
78. Queitsch, C.; Sangster, T. A.; Lindquist, S. Hsp90 as a Capacitor of Phenotypic Variation. Nature 2002, 417, 618-624.
79. Price, P. J.; Suk, W. A.; Skeen, P. C.; Spahn, G. J.; Chirigos, M. A. Geldanamycin Inhibition of 3-Methylcholanthrene-Induced Rat Embryo Cell Transformation. Proc. Soc. Exp. Biol. Med. 1977, 155, 461-463.
80. Clarke, P. A.; Hostein, I.; Bancrji, U.; Stefano, F. D.; Maloney, A.; Walton, M.; Judson, I.; Workman, P. Gene Expression Profiling of Human Colon Cancer Cells Following Inhibition of Signal Transduction by 17-Allylamino-17-Demethoxygeldanamycin, an Inhibitor of the Hsp90 Molecular Chaperone. Oncogene 2000, 19, 4125-4133.
81. Panaretou, B.; Prodromou, C.; Roe, S. M.; O'Brien, R.; Ladbury, J. E.; Piper, P. W.; Pearl, L. H. ATP Binding and Hydrolysis Are Essential to the Function of the Hsp90 Molecular Chaperone in Vivo. EMBO J. 1998, 17, 4829-4836.
82. Aherne, W.; Maloney, A.; Prodromou, C; Rowlands, M. G.; Hardcastle, A.; Boxall, K.; Clarke, P.; Walton, M.; Pearl, L.; Workman, P. Assays for Hsp90 and Inhibitors. In Novel Anticancer Drug Protocols, Methods in Molecular Medicine Vol. 85; Buolamwini J. K.; Adjei, A. A., Eds.; Humana Press: Totowa, NJ, 2003, pp.
83. Blake, M. J.; Gershon, D.; Fargnoli, J.; Holbrook, N. J. Discordant Expression of Heat Shock Protein Mrnas in Tissues of Heat-Stressed Rats. J. Biol. Chem. 1990, 265, 15275-15279.
84. Lu, A.; Ran, R.; Parmentier-Batteur, S.; Nee, A.; Sharp, F. R. Geldanamycin Induces Heat Shock Proteins in Brain and Protects against Focal Cerebral Ischemia. J. Neurochem. 2002, 81, 355-364.
85. Marcuccilli, C. J.; Mathur, S. K.; Morimoto, R. I.; Miller, R. J. Regulatory Differences in the Stress Response of Hippocampal Neurons and Glial Cells After Heat Shock. J. Neurosci. 1996, 16, 478-485.
86. Mathur, S. K.; Sistonen, L.; Brown, I. R.; Murphy, S. P.; Sarge, K. D.; Morimoto, R. I. Deficient Induction of Human Hsp70 Heat Shock Gene Transcription in Y79 Retinoblastoma Cells Despite Activation of Heat Shock Factor 1. Proc. Natl. Acad. Sci. USA 1994, 91, 8695-8699.
87. Fawcett, T. W.; Xu, Q.; Holbrook, N. J. Potentiation of Heat Stress-Induced Hsp70 Expression in Vivo by Aspirin. Cell Stress Chap. 1997, 2, 104-109.
88. Lee, B. S.; Chen, J.; an gelidis, C.; Jurivich, D. A.; Morimoto, R. I. Pharmacological Modulation of Heat Shock Factor I by an tiinflammatory Drugs Results in Protection against Stress-Induced Cellular Damage. Proc. Natl. Acad. Sci. USA 1995, 92, 7207-7211.
89. Hansen, R. K.; Oesterreich, S.; Lemieux, P.; Sarge, K. D.; Fuqua, S. A. Quercetin Inhibits Heat Shock Protein Induction But Not Heat Shock Factor DNA-Binding in Human Breast Carcinoma Cells. Biochem. Biophys. Res. Comm. 1997, 239, 851-856.
90. Elia, G.; Amici, C.; Rossi, A.; Santoro, M. G. Modulation of Prostaglandin Al-Induced Thermotolerance by Quercetin in Human Leukemic Cells: Role of Heat Shock Protein 70. Cancer Res. 1996, 56, 210-217.
91. Ferry, D. R.; Smith, A.; Malkhandi, J.; Fyfe, D. W.; Detakats, P. G.; and erson, D.; Baker, J.; Kerr, D. J. Phase I Clinical Trial of the Flavonoid Quercetin: Pharmacokinetics and Evidence for in Vivo Tyrosine Kinase Inhibition. Clin. Cancer Res. 1996, 2, 659-668.
92. Mulholland, P. J.; Ferry, D. R.; and erson, D.; Hussain, S. A.; Young, A. M.; Cook, J. E.; Hodgkin, E.; Seymour, L. W.; Kerr, D. J. Pre-Clinical and Clinical Study of QC12, a Water-Soluble, Pro-Drug of Quercetin. Ann. Oncol. 2001, 12, 245-248.
93. Hutter, J. J.; Mestril, R.; Tam, E. K.; Sievers, R. E.; Dillmann, W. H.; Wolfe, C. L. Overexpression of Heat Shock Protein 72 in Transgenic Mice Decreases Infarct Size in Vivo. Circulation. 1996, 94, 1408-1411.
94. Trost, S. U.; Omens, J. H.; Karlon, W. J.; Meyer, M.; Mestril, R.; Covell, J. W.; Dillmann, W. H. Protection against Myocardial Dysfunction after a Brief Ischemic Period in Transgenic Mice Expressing Inducible Heat Shock Protein 70. J. Clin. Invest. 1998, 101, 855-862.
95. Plumier, J. C.; Krueger, A. M.; Currie, R. W.; Kontoyiannis, D.; Kollias, G.; Pagoulatos, G. N. Transgenic Mice Expressing the Human Inducible Hsp70 Have Hippocampal Neurons Resistant to Ischemic Injury. Cell Stress Chap. 1997, 2, 162-167.
96. Rajdev, S.; Hara, K.; Kokubo, Y.; Mestril, R.; Dillmann, W.; Weinstein, P. R.; Sharp, F. R. Mice Overexpressing Rat Heat Shock Protein 70 Are Protected against Cerebral Infarction. Ann. Neurol. 2000, 47, 782-791.
97. Conde, A. G.; Lau, S. S.; Dillmann, W. H.; Mestril, R. Induction of Heat Shock Proteins by Tyrosine Kinase Inhibitors in Rat Cardiomyocytes and Myogenic Cells Confers Protection against Simulated Ischemia. J. Mol. Cell Cardiol. 1997, 29, 1927-1938.
98. Tatzelt, J.; Zuo, J.; Voellmy, R.; Scott, M.; Hartl, U.; Prusiner, S. B. ; Welch, W. J. Scrapie Prions Selectively Modify the Stress Response in Neuroblastoma Cells. Proc. Natl. Acad. Sci. USA 1995, 92, 2944-2948.
99. Winklhofer, K. F.; Reintjes, A.; Hoener, M. C.; Voellmy, R.; Tatzelt, J. Geldanamycin Restores a Defective Heat Shock Response in Vivo. J. Biol. Chem. 2001, 276, 45160-45167.
100. Sittler, A.; Lurz, R.; Lueder, G.; Priller, J.; Hayer-Hartl, M. K.; Hartl, F. U.; Lehrach, H.; Wanker, E. E. Geldanamycin Activates a Heat Shock Response and Inhibits Huntingtin Aggregation in a Cell Culture Model of Huntington's Disease. Hum. Mol. Genet. 2001, 10, 1307-1315.